- Home
- CLH vs NBIX Comparison
CLH vs NBIX Comparison
Compare CLH & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLH
- NBIX
- Stock Information
- Founded
- CLH 1980
- NBIX 1992
- Country
- CLH United States
- NBIX United States
- Employees
- CLH N/A
- NBIX N/A
- Industry
- CLH Environmental Services
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLH Industrials
- NBIX Health Care
- Exchange
- CLH Nasdaq
- NBIX Nasdaq
- Market Cap
- CLH 10.3B
- NBIX 11.0B
- IPO Year
- CLH 1987
- NBIX 1996
- Fundamental
- Price
- CLH $225.69
- NBIX $115.71
- Analyst Decision
- CLH Strong Buy
- NBIX Strong Buy
- Analyst Count
- CLH 9
- NBIX 20
- Target Price
- CLH $247.67
- NBIX $163.20
- AVG Volume (30 Days)
- CLH 436.6K
- NBIX 1.8M
- Earning Date
- CLH 04-30-2025
- NBIX 05-05-2025
- Dividend Yield
- CLH N/A
- NBIX N/A
- EPS Growth
- CLH 4.50
- NBIX N/A
- EPS
- CLH 7.22
- NBIX 2.96
- Revenue
- CLH $5,945,207,000.00
- NBIX $2,412,600,000.00
- Revenue This Year
- CLH $5.84
- NBIX $15.36
- Revenue Next Year
- CLH $6.22
- NBIX $16.34
- P/E Ratio
- CLH $31.25
- NBIX $39.66
- Revenue Growth
- CLH 8.52
- NBIX 21.73
- 52 Week Low
- CLH $178.29
- NBIX $84.23
- 52 Week High
- CLH $267.11
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- CLH 70.27
- NBIX 60.88
- Support Level
- CLH $219.81
- NBIX $105.45
- Resistance Level
- CLH $229.68
- NBIX $130.46
- Average True Range (ATR)
- CLH 4.76
- NBIX 4.31
- MACD
- CLH 1.47
- NBIX 1.96
- Stochastic Oscillator
- CLH 84.61
- NBIX 50.22
About CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.